Astrid van der Veldt

Dr. Astrid van der Veldt is a researcher at Erasmus MC, jointly affiliated with the Department of Radiology & Nuclear Medicine and the Department of Medical Oncology. Her work bridges imaging and clinical oncology, with a strong focus on melanoma and immunotherapeutic interventions.

• Institution: Erasmus MC
• Departments: Radiology & Nuclear Medicine, Medical Oncology
• Role: Researcher

Her research centers on melanoma treatment, particularly the use of immune checkpoint inhibitors and targeted therapies like BRAF/MEK inhibitors. She investigates treatment outcomes, resistance mechanisms, and adverse events, especially in metastatic and elderly populations. Her work integrates functional imaging (e.g., [18F]FDG PET/CT) to identify predictive biomarkers for therapy response.

The recent publications reflect a strong trend in clinical oncology research with an emphasis on real-world data from national registries, patient-centered outcomes, and safety profiling of immunotherapies. Her studies frequently address translational questions linking imaging, molecular profiling, and clinical endpoints.

While no specific awards are listed in the provided text, her extensive publication record in journals like European Journal of Cancer and Immuno-Oncology and Technology indicates significant scholarly impact.

Dr. van der Veldt is actively involved in mentoring and research supervision, with at least 5 supervised works documented. Her collaborative network spans multiple Dutch cancer centers, particularly through the Dutch Melanoma Treatment Registry. She contributes to both clinical research and evidence-based oncology practice through population-level studies and biomarker validation.

She is a key contributor to multidisciplinary oncology research at Erasmus MC, working at the intersection of nuclear medicine, radiology, and systemic cancer therapy. Her team-based research approach leverages large-scale clinical data and advanced imaging to improve personalized treatment strategies for melanoma patients.